Garadah Taysir S, Kassab Salah, Al-Shboul Qasim M, Alawadi Abdulhai
Cardiac Unit, Salmaniya Medical Complex.
Clin Med Cardiol. 2009 Apr 1;3:29-36. doi: 10.4137/cmc.s2289.
Recent studies indicated a high prevalence of hyperglycemia in non-diabetic patients presenting with acute coronary syndrome (ACS). However, the threshold of admission glucose (AG) as a predictor of adverse events in ACS is unclear.
The aim of this study was to assess the threshold of admission glucose (AG) as a predictor of adverse events including Major Acute Cardiac Events (MACE) and mortality, during the first week of admitting patients presenting with ACS.
The data of 551 patients with ACS were extracted and evaluated. Patients were stratified according to their blood glucose on admission into three groups: group 1: </=7 mmol/L (n = 200, 36.3%) and group 2: >7 mmol/L and <15 mmol/L (n = 178, 32.3%) and group 3: >/=15 mmol/L (n = 173, 31.4%). Stress hyperglycemia was arbitrarily defined as AG levels > 7 mmol/L (group 2 and 3). Patients with ACS were sub-divided into two groups: patients with unstable angina (UA, n = 285) and those with ST segment elevation myocardial Infarction (STEMI, n = 266) and data were analyzed separately using multiple regression analysis.
The mean age of patients was 59.7 +/- 14.8 years and 63% were males. The overall mortality in the population was 8.5% (5.4% in STEMI and 3.1% in UA) patients. In STEMI patients, the odds ratio of stress hyperglycemia as predictor of mortality in group 3 compared with group 1 was 3.3 (CI 0.99-10.98, P < 0.05), while in group 2 compared with group 1 was 2.4 (CI: 0.75-8.07, P = 0.065) after adjustment for age and sex. Similarly, in UA patients, the odds ratio of stress hyperglycemia in group 3 compared with group 1 was 2.7 (CI 0.37-18.98, P < 0.05), while in group 2 compared with group 1 was 2.4 (CI: 0.4-15.2, P = 0.344) after adjustment for age and sex. The incidence of more than 2 MACE in both STEMI and UA patients was higher in group 3 compared with the other two groups. Regression analysis showed that history of DM, high level of LDL cholesterol, high level of HbA1c, and anterior infarction were significant predictors of adverse events while other risk factors such as BMI, history of hypertension and smoking were of no significance.
This study indicates that the stress hyperglycemia on admission is a powerful predictor of increased major adverse events and hospital mortality in patients with acute coronary syndrome.
近期研究表明,在患有急性冠状动脉综合征(ACS)的非糖尿病患者中,高血糖症的患病率很高。然而,入院血糖(AG)作为ACS不良事件预测指标的阈值尚不清楚。
本研究的目的是评估入院血糖(AG)作为预测ACS患者入院第一周内包括主要急性心脏事件(MACE)和死亡率等不良事件的阈值。
提取并评估了551例ACS患者的数据。根据患者入院时的血糖水平将其分为三组:第1组:≤7 mmol/L(n = 200,36.3%);第2组:>7 mmol/L且<15 mmol/L(n = 178,32.3%);第3组:≥15 mmol/L(n = 173,31.4%)。应激性高血糖被随意定义为AG水平>7 mmol/L(第2组和第3组)。将ACS患者分为两组:不稳定型心绞痛(UA,n = 285)患者和ST段抬高型心肌梗死(STEMI,n = 266)患者,并使用多元回归分析分别对数据进行分析。
患者的平均年龄为59.7±14.8岁,63%为男性。总体人群死亡率为8.5%(STEMI患者为5.4%,UA患者为3.1%)。在STEMI患者中,校正年龄和性别后,第3组应激性高血糖作为死亡率预测指标的比值比为3.3(CI 0.99 - 10.98,P < 0.05),而第2组与第1组相比为2.4(CI:0.75 - 8.07,P = 0.065)。同样,在UA患者中,校正年龄和性别后,第3组应激性高血糖与第1组相比的比值比为2.7(CI 0.37 - 18.98,P < 0.05),而第2组与第1组相比为2.4(CI:0.4 - 15.2,P = 0.344)。第3组STEMI和UA患者中发生2次以上MACE的发生率高于其他两组。回归分析表明,糖尿病史、高水平的低密度脂蛋白胆固醇、高水平的糖化血红蛋白和前壁梗死是不良事件的重要预测指标,而其他危险因素如体重指数、高血压病史和吸烟则无显著意义。
本研究表明,入院时的应激性高血糖是急性冠状动脉综合征患者主要不良事件增加和医院死亡率升高的有力预测指标。